中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(11): 2622-2625

A preliminary study on percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy in treatment of refractory liver abscess

DOI: 10.3969/j.issn.1001-5256.2021.11.026
  • 1.

    Department of Hepatobiliary Surgery, The Affiliated 3201 Hospital of Xi'an Jiaotong University School of Medicine, Hanzhong, Shaanxi 723000, China

  • 2.

    Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Research funding:

Natural Science Foundation of Heilongjiang (H2018025)

  • Received Date: 2021-03-17
  • Accepted Date: 2021-03-30
  • Published Date: 2021-11-20
    Abstract
  •   Objective  To investigate the clinical effect of percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy for necrosectomy and drainage in the treatment of refractory liver abscess after transcatheter arterial embolization (TACE).  Methods  A retrospective analysis was performed for three patients with refractory liver abscess after TACE in The Affiliated 3201 Hospital of Xi'an Jiaotong University School of Medicine from January 2018 to December 2020, and among the three patients, one had the formation of liver abscess after TACE for hepatic metastases after pancreaticoduodenectomy, one had liver abscess after repeated TACE for massive hepatocellular carcinoma, and one had secondary liver abscess after TACE for traumatic hepatic rupture. All three patients received percutaneous transhepatic drainage and sequential percutaneous nephroscopy for the treatment of refractory liver abscess, and their specific treatment process was summarized.  Results  All three patients were diagnosed with refractory liver abscess based on CT, routine blood test, procalcitonin, blood culture, and clinical manifestation. Percutaneous transhepatic catheterization under the guidance of conventional ultrasonography or CT and effective antibiotics had an unsatisfactory therapeutic effect, and after sequential percutaneous nephroscopy was performed for necrosectomy and drainage, liver abscess was cured and the patients had good prognosis.  Conclusion  For refractory liver abscess after TACE, when routine puncture treatment has an unsatisfactory therapeutic effect or a patient cannot tolerate surgical operation, percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy is safe and effective in the treatment of refractory liver abscess.

     

    • FullText(HTML)
  • loading
    • References(12)
  • [1]
    BROWN DB, GESCHWIND JF, SOULEN MC, et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies[J]. J Vasc Interv Radiol, 2009, 20(7 Suppl): s317-323. DOI: 10.1016/j.jvir.2009.04.015.
    [2]
    NAULT JC, SUTTER O, NAHON P, et al. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations[J]. J Hepatol, 2018, 68(4): 783-797. DOI: 10.1016/j.jhep.2017.10.004.
    [3]
    LI M, LU YY, DONG JH, et al. Clinical effect of transcatheter arterial chemoembolization combined with microwave ablation in treatment of advanced primary liver cancer[J]. J Clin Hepatol, 2020, 36(12): 2720-2724. DOI: 10.3969/j.issn.1001-5256.2020.12.016.

    李猛, 陆荫英, 董景辉, 等. 经肝动脉化疗栓塞术联合微波消融治疗中晚期原发性肝癌的效果分析[J]. 临床肝胆病杂志, 2020, 36(12): 2720-2724. DOI: 10.3969/j.issn.1001-5256.2020.12.016.
    [4]
    LI JH, YAO RR, SHEN HJ, et al. Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma[J]. World J Gastroenterol, 2015, 21(14): 4397-4401. DOI: 10.3748/wjg.v21.i14.4397.
    [5]
    HUANG Y, ZHANG WH. Research advances in diagnosis and treatment of bacterial liver abscess[J]. J Clin Hepatol, 2018, 34(3): 641-644. DOI: 10.3969/j.issn.1001-5256.2018.03.045.

    黄洋, 张伟辉. 细菌性肝脓肿的诊治进展[J]. 临床肝胆病杂志, 2018, 34(3): 641-644. DOI: 10.3969/j.issn.1001-5256.2018.03.045.
    [6]
    WI JW, CHO EA, JUN CH, et al. Clinical characteristics and outcomes of pyogenic liver abscess in elderly Korean patients[J]. Korean J Gastroenterol, 2015, 66(1): 27-32. DOI: 10.4166/kjg.2015.66.1.27.
    [7]
    CAI MT, LIANG LC. Pathogen distribution and drug resistance in liver cancer patients with liver abscess after transarterial chemoembolization or ablation[J]. J Clin Hepatol, 2020, 36(1): 118-122. DOI: 10.3969/j.issn.1001-5256.2020.01.026.

    蔡妙甜, 梁连春. 原发性/转移性肝癌患者经肝动脉化疗栓塞术或消融术后发生肝脓肿的病原菌分布及耐药性分析[J]. 临床肝胆病杂志, 2020, 36(1): 118-122. DOI: 10.3969/j.issn.1001-5256.2020.01.026.
    [8]
    ZHU QL, XIANG XX, YUAN LY, et al. Clinical effect of ultrasound-guided percutaneous drainage in treatment of liver abscess[J]. J Clin Hepatol, 2019, 35(6): 1318-1321. DOI: 10.3969/j.issn.1001-5256.2019.06.027.

    朱沁玲, 向晓星, 袁乐瑶, 等. 超声引导下经皮穿刺引流治疗肝脓肿的效果观察[J]. 临床肝胆病杂志, 2019, 35(6): 1318-1321. DOI: 10.3969/j.issn.1001-5256.2019.06.027.
    [9]
    PICKENS RC, JENSEN S, SULZER JK, et al. Minimally invasive surgical management as effective first-line treatment of large pyogenic hepatic abscesses[J]. Am Surg, 2019, 85(8): 813-820.
    [10]
    BEI YF. Clinical effect and feasibility of laparoscopic catheter drainage versus incision and drainage in treatment of liver abscess[J]. Chin Hepatol, 2015, 20(6): 499. DOI: 10.3969/j.issn.1008-1704.2015.06.025.

    贝云枫. 腹腔镜下行肝脓肿置管引流和切开引流的疗效及可行性分析[J]. 肝脏, 2015, 20(6): 499. DOI: 10.3969/j.issn.1008-1704.2015.06.025.
    [11]
    SHIN JU, KIM KM, SHIN SW, et al. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma[J]. Dig Liver Dis, 2014, 46(9): 813-817. DOI: 10.1016/j.dld.2014.05.003.
    [12]
    JIA Z, TU J, CAO C, et al. Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma: A retrospective analysis of 23 cases[J]. J Cancer Res Ther, 2018, 14(Supplement): S628-S633. DOI: 10.4103/0973-1482.199385.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (373) PDF downloads(31) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return